-----Original Message----- From: StemCells, Inc. [mailto:[log in to unmask]] Sent: Thursday, October 04, 2012 09:06 To: [log in to unmask] Subject: StemCells, Inc. Announces First Transplant of Neural Stem Cells Into Patient in Clinical Trial for Dry Age-Related Macular Degeneration <http://media.corporate-ir.net/media_files/IROL/86/86230/email_h.jpg> StemCells, Inc. has added a news release to its Investor Relations website. Title: StemCells, Inc. Announces First Transplant of Neural Stem Cells Into Patient in Clinical Trial for Dry Age-Related Macular Degeneration Date(s): 4-Oct-2012 9:01 AM For a complete listing of our news releases, please click here <http://investor.stemcellsinc.com/phoenix.zhtml?c=86230&p=irol-news&nyo=0> ________________________________ If you are unable to click on the link above, please copy and paste the URL below into a web browser http://investor.stemcellsinc.com/phoenix.zhtml?c=86230&p=irol-news&nyo=0 Thomson Reuters Inc. 22 Thomson Place Boston, MA 02210 Click Here <http://origin-www.corporate-ir.net/ireye/unsubscribe.zhtml?t=2743&a=ir-news > to unsubscribe from this JoinMail list. ________________________________ ----------------------- To change your mail settings or leave the C-PALSY list, go here: http://listserv.icors.org/SCRIPTS/WA-ICORS.EXE?SUBED1=c-palsy